Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.7.2022Zentiva a.s. (ZNT-SK-2)44300RISENDROS 35 mg (tbl flm 4x35 mg (blis. OPA/Al/PVC/Al))18.7.2022O
 18.7.2022Zentiva a.s. (ZNT-SK-2)44310RISENDROS 35 mg (tbl flm 12x35 mg (blis. OPA/Al/PVC/Al))18.7.2022O
 18.7.2022Zentiva, k.s. (ZNT-1)1797DGUAJACURAN (tbl obd 50x200 mg (blis.Al/PVC))18.7.2022R
 18.7.2022Zentiva, k.s. (ZNT-1)2512DZetovar 10 mg/40 mg tablety (tbl 30x10 mg/40 mg (blis.OPA/Al/PVC))18.7.2022O
 18.7.2022Zentiva, k.s. (ZNT-1)94234GUAJACURAN (tbl obd 30x200 mg (blis.Al/PVC))18.7.2022R
 15.7.2022TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)51861Montelukast Teva 4 mg (tbl mnd 28x4 mg (blis.Al/Al))22.7.2022O
 14.7.2022Actavis Group PTC ehf. (ACT-5)31908Desloratadine Actavis 5 mg filmom obalené tablety (tbl flm 50x5 mg (blis.OPA/Al/PVC/Al))10.9.2022R
 14.7.2022Actavis Group PTC ehf. (ACT-5)35947Betahistin Actavis 16 mg (tbl 60x16 mg)30.8.2022R
 14.7.2022Teva B.V. (TEV-NL-4)8602BAtomoxetine Actavis 40 mg (cps dur 28x40 mg (blis.PVC/PVDC/PVC/Al))30.8.2022R
 14.7.2022Teva B.V. (TEV-NL-4)83271Talopam 100 mg (tbl flm 60x100 mg (blis.Al/Al))10.8.2022R
 14.7.2022Teva B.V. (TEV-NL-4)90406Carvedilol-Teva 25 mg (tbl 30x25 mg (blis.PVC/PVDC/Al))22.7.2022O
 14.7.2022Teva B.V. (TEV-NL-4)91386Gabapentin-Teva 400 mg (cps dur 200(2x100)x400 mg (blis.PVC/PVDC/Al))22.7.2022O
 14.7.2022ratiopharm GmbH (RAT)36737Valpro-ratiopharm Chrono 500 mg (tbl plg 100x500 mg (blis.Al/PVC))22.7.2022R
 14.7.2022ratiopharm GmbH (RAT)51662Perindocombi 4 mg/1,25 mg (tbl 90x4 mg/1,25 mg (blis.PA/Al/PVC/Al))22.7.2022O
 14.7.2022ratiopharm GmbH (RAT)85145Ratiograstim 30 MIU/0,5 ml injekčný alebo infúzny roztok (sol ijf 5x0,5 ml/300 µg (30 MIU) (striek.skl.napln. s bezp.zar.))24.8.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To